
Please try another search
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Deirdre A. Mahlan | 61 | - | Independent Non-Executive Director |
Manvinder Singh Banga | 69 | - | Senior Independent Non-Executive Director |
Asmita Dubey | 48 | - | Independent Non-Executive Director |
Marie-Anne Aymerich | 56 | - | Independent Non-Executive Director |
Dame Vivienne Cox | 64 | - | Independent Non-Executive Director |
Tracy Jayne Clarke | 56 | - | Independent Non-Executive Director |
David M. Denton | 58 | 2023 | Non-Executive Director |
Bryan Supran | 52 | 2022 | Non-Executive Director |
Brian McNamara | 56 | 2021 | CEO & Executive Director |
Tobias Hestler | 50 | 2021 | CFO & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review